Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price rose 9.1% on Tuesday . The stock traded as high as $2.74 and last traded at $2.72. Approximately 220,664 shares were traded during trading, a decline of 73% from the average daily volume of 811,455 shares. The stock had previously closed at $2.49.
Analysts Set New Price Targets
Separately, Cormark raised shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a research note on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Strong Buy".
Get Our Latest Stock Report on Curaleaf
Curaleaf Stock Performance
The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70. The stock's 50 day simple moving average is $2.28 and its two-hundred day simple moving average is $1.37. The stock has a market cap of $1.76 billion, a P/E ratio of -8.22 and a beta of 0.75.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.